Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
N
380550
vs
K
KOSPI 200
Over the past 12 months, Neurophet Inc has underperformed KOSPI 200, delivering a return of -14% compared to KOSPI 200's +116% growth.
Stocks Performance
380550 vs KOSPI 200
Performance Gap
380550 vs KOSPI 200
Performance By Year
380550 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Neurophet Inc
Glance View
Neurophet, Inc. engages in the development of advanced neuroscience technologies. The company is headquartered in Seoul, Seoul. The company went IPO on 2025-07-25. The firm is mainly engaged in the development and sale of positron emission tomography (PET) image quantitative analysis software ‘Neurophet SCALE PET’, neurodegenerative brain disease diagnosis support software ‘Neurophet AQUA’, as well as Alzheimer’s disease imaging biomarker solution 'Neurophet AQUA AD' and other products. The firm is also engaged in the development and sale of therapeutic medical devices. In addition, the Company provides clinical research support services and brain stimulation therapy solutions.